peritoneal cancer
Elahere Fully Approved for Certain Ovarian, Fallopian Tube or Primary Peritoneal Cancer
The FDA approved Elahere for adult patients with FRalpha-positive, platinum-resistant epithelial ovarian, fallopian ...
MARCH 25, 2024
FDA Grants New Indication for Rubraca
The FDA granted a new indication for Rubraca for the maintenance treatment of recurrent ovarian, fallopian tube or ...
APRIL 6, 2018
Load more